Board Change • May 20
Less than half of directors are independent There are 9 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Independent Director Yuenian Hu is the most experienced director on the board, commencing their role in 2025. Independent Director Yi Sha was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Aankondiging • Apr 23
Suli Co., Ltd., Annual General Meeting, May 29, 2026 Suli Co., Ltd., Annual General Meeting, May 29, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Jiangyin, Jiangsu China Aankondiging • Mar 30
Suli Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Suli Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Aankondiging • Dec 26
Suli Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Suli Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Aankondiging • Sep 30
Suli Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Suli Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 Aankondiging • Jun 30
Suli Co., Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Suli Co., Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 Aankondiging • Mar 28
Suli Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Suli Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Aankondiging • Dec 27
Suli Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Suli Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.011 (vs CN¥0.022 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.011 (up from CN¥0.022 loss in 3Q 2023). Revenue: CN¥604.7m (up 32% from 3Q 2023). Net income: CN¥2.08m (up CN¥6.04m from 3Q 2023). Profit margin: 0.3% (up from net loss in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Aankondiging • Sep 30
Suli Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Suli Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 New Risk • Sep 15
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 21% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Reported Earnings • Aug 22
Second quarter 2024 earnings released: EPS: CN¥0.057 (vs CN¥0.10 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.057 (down from CN¥0.10 in 2Q 2023). Revenue: CN¥556.2m (up 18% from 2Q 2023). Net income: CN¥9.61m (down 47% from 2Q 2023). Profit margin: 1.7% (down from 3.8% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings. Aankondiging • Jun 28
Suli Co., Ltd. to Report First Half, 2024 Results on Aug 22, 2024 Suli Co., Ltd. announced that they will report first half, 2024 results on Aug 22, 2024 Declared Dividend • Jun 27
Dividend of CN¥0.05 announced Shareholders will receive a dividend of CN¥0.05. Ex-date: 1st July 2024 Payment date: 1st July 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 76 years, indicating a lack of growth and stability in payments. Aankondiging • Apr 24
Suli Co., Ltd., Annual General Meeting, May 22, 2024 Suli Co., Ltd., Annual General Meeting, May 22, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Jiangyin, Jiangsu China Reported Earnings • Apr 24
First quarter 2024 earnings released: CN¥0.02 loss per share (vs CN¥0.12 profit in 1Q 2023) First quarter 2024 results: CN¥0.02 loss per share (down from CN¥0.12 profit in 1Q 2023). Revenue: CN¥485.5m (down 12% from 1Q 2023). Net loss: CN¥3.12m (down 114% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Aankondiging • Mar 29
Suli Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 Suli Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥11.27, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years. Aankondiging • Dec 29
Suli Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 Suli Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Reported Earnings • Oct 31
Third quarter 2023 earnings released: CN¥0.022 loss per share (vs CN¥0.36 profit in 3Q 2022) Third quarter 2023 results: CN¥0.022 loss per share (down from CN¥0.36 profit in 3Q 2022). Revenue: CN¥457.0m (down 42% from 3Q 2022). Net loss: CN¥3.96m (down 106% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Aankondiging • Sep 30
Suli Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023 Suli Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023 Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.56 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.56 in 2Q 2022). Revenue: CN¥473.0m (down 44% from 2Q 2022). Net income: CN¥18.1m (down 82% from 2Q 2022). Profit margin: 3.8% (down from 12% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Aankondiging • Jun 28
Suli Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023 Suli Co., Ltd. announced that they will report first half, 2023 results on Aug 29, 2023 Reported Earnings • Apr 30
First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.55 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.12 (down from CN¥0.55 in 1Q 2022). Revenue: CN¥552.1m (down 31% from 1Q 2022). Net income: CN¥22.1m (down 78% from 1Q 2022). Profit margin: 4.0% (down from 12% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Rongjun Hua was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.23 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.36 (up from CN¥0.23 in 3Q 2021). Revenue: CN¥791.3m (up 32% from 3Q 2021). Net income: CN¥66.0m (up 56% from 3Q 2021). Profit margin: 8.3% (up from 7.0% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has remained flat. Reported Earnings • Aug 20
Second quarter 2022 earnings released: EPS: CN¥0.56 (vs CN¥0.33 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.56 (up from CN¥0.33 in 2Q 2021). Revenue: CN¥848.6m (up 52% from 2Q 2021). Net income: CN¥100.9m (up 71% from 2Q 2021). Profit margin: 12% (up from 11% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: CN¥0.55 (vs CN¥0.21 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.55 (up from CN¥0.21 in 1Q 2021). Revenue: CN¥794.7m (up 91% from 1Q 2021). Net income: CN¥98.2m (up 159% from 1Q 2021). Profit margin: 12% (up from 9.1% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 5 independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 09
Full year 2021 earnings released: EPS: CN¥1.29 (vs CN¥0.97 in FY 2020) Full year 2021 results: EPS: CN¥1.29 (up from CN¥0.97 in FY 2020). Revenue: CN¥2.29b (up 47% from FY 2020). Net income: CN¥232.4m (up 33% from FY 2020). Profit margin: 10% (down from 11% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.24 in 3Q 2020) The company reported a mediocre third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥601.7m (up 35% from 3Q 2020). Net income: CN¥42.4m (down 3.4% from 3Q 2020). Profit margin: 7.0% (down from 9.9% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 13
Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.26 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥558.5m (up 63% from 2Q 2020). Net income: CN¥58.9m (up 25% from 2Q 2020). Profit margin: 11% (down from 14% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 28
First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.22 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: CN¥415.7m (up 29% from 1Q 2020). Net income: CN¥38.0m (down 2.9% from 1Q 2020). Profit margin: 9.1% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year and the company’s share price has also fallen by 14% per year. Reported Earnings • Mar 24
Full year 2020 earnings released: EPS CN¥0.97 (vs CN¥1.68 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.56b (down 14% from FY 2019). Net income: CN¥174.7m (down 42% from FY 2019). Profit margin: 11% (down from 17% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 12% per year. Is New 90 Day High Low • Jan 27
New 90-day low: CN¥14.98 The company is down 12% from its price of CN¥17.04 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥15.80, the stock is trading at a trailing P/E ratio of 15x, down from the previous P/E ratio of 17.8x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 34%. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥15.80 The company is down 11% from its price of CN¥17.80 on 14 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Dec 11
New 90-day high: CN¥18.67 The company is up 2.0% from its price of CN¥18.29 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥17.04 The company is down 9.0% from its price of CN¥18.64 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Reported Earnings • Oct 29
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥189.9m, down 42% from the prior year. Total revenue was CN¥1.54b over the last 12 months, down 16% from the prior year.